| Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing G Guo, NS Raje, C Seifer, J Kloeber, R Isenhart, G Ha, AJ Yee, ... Leukemia 32 (8), 1838-1841, 2018 | 53 | 2018 |
| Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL P Anand, A Guillaumet-Adkins, V Dimitrova, H Yun, Y Drier, N Sotudeh, ... Blood, The Journal of the American Society of Hematology 137 (18), 2463-2480, 2021 | 42 | 2021 |
| A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma GJ Hanna, A ONeill, JM Cutler, M Flynn, T Vijaykumar, JR Clark, LJ Wirth, ... Oral Oncology 119 (105366), 2021 | 35 | 2021 |
| Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering L Li, V Mohanty, J Dou, Y Huang, PP Banerjee, Q Miao, JG Lohr, ... Science Advances 9 (30), eadd6997, 2023 | 34 | 2023 |
| Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma J Frede, P Anand, N Sotudeh, RA Pinto, MS Nair, H Stuart, AJ Yee, ... Nature Cell Biology 23 (11), 1199-1211, 2021 | 29 | 2021 |
| The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model PJ Ghumatkar, SP Patil, V Peshattiwar, T Vijaykumar, V Dighe, G Vanage, ... Naunyn-Schmiedeberg's Archives of Pharmacology 392, 327-339, 2019 | 26 | 2019 |
| Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma JM Waldschmidt, JA Kloeber, P Anand, J Frede, A Kokkalis, V Dimitrova, ... Clinical Cancer Research 27 (23), 6432-6444, 2021 | 23 | 2021 |
| Bisphenol A-induced ultrastructural changes in the testes of common marmoset T Vijaykumar, D Singh, GR Vanage, RV Dhumal, VD Dighe Indian Journal of Medical Research 146 (1), 126-137, 2017 | 22 | 2017 |
| Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry AP Lawson, DW Bak, DA Shannon, MJC Long, T Vijaykumar, R Yu, ... Oncotarget 8 (31), 51296, 2017 | 16 | 2017 |
| Cell-free DNA for the detection of emerging treatment failure in relapsed/refractory multiple myeloma JM Waldschmidt, AJ Yee, T Vijaykumar, RA Pinto, J Frede, P Anand, ... Leukemia 36 (4), 1078-1087, 2022 | 15 | 2022 |
| Tracking myeloma tumor DNA in peripheral blood JM Waldschmidt, T Vijaykumar, B Knoechel, JG Lohr Best Practice & Research Clinical Haematology 33 (1), 101146, 2020 | 8 | 2020 |
| Efficacy and safety of a herbo-mineral ayurvedic formulation ‘afrodet Plus®’in male rats R Dhumal, T Vijaykumar, V Dighe, N Selkar, M Chawda, M Vahlia, ... Journal of Ayurveda and integrative medicine 4 (3), 158, 2013 | 6 | 2013 |
| Dual role of signaling pathways in myeloma requires cell-type specific targeting of ligand-receptor interactions. P Hernandez-Lopez, T Vijaykumar, P Anand, D Auclair, J Frede, ... Blood Advances, bloodadvances. 2023011463, 2024 | 1 | 2024 |
| Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy JM Waldschmidt, S Arora, T Vijaykumar, N Sotudeh, P Anand, H Stuart, ... Blood 140 (Supplement 1), 9925-9926, 2022 | 1 | 2022 |
| S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT J Frede, J Poller, K Shi, H Stuart, N Sotoudeh, K Lim, C Wiggers, ... HemaSphere 7 (Suppl), 2023 | | 2023 |
| Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy J Frede, P Anand, AJ Yee, T Vijaykumar, MS Nair, JM Waldschmidt, ... Blood 134, 3091, 2019 | | 2019 |
| Chromatin Structure Dynamics Preserve Genome Stability in Multiple Myeloma A Kokkalis, P Anand, MS Nair, JM Waldschmidt, J Frede, T Vijaykumar, ... Blood 134, 1777, 2019 | | 2019 |
| Determining resistance mechanisms in BRAF-mutated multiple myeloma JM Waldschmidt, JA Kloeber, T Vijaykumar, A Kokkalis, P Anand, ... Blood 134, 316, 2019 | | 2019 |
| Circulating tumor DNA in the peripheral blood as early predictor of clinical outcome in relapsed/refractory multiple myeloma JM Waldschmidt, AJ Yee, T Vijaykumar, J Frede, P Anand, S Potdar, ... Blood 134, 4350, 2019 | | 2019 |
